Surge in GLP-1 Drugs for Weight Loss Sparks Concerns Over Diabetes Treatment

As more people use GLP-1 medications for obesity, shortages impact diabetes patients' access to these critical drugs.

GLP-1 drugs, initially developed for diabetes, are now widely used for weight loss.
High demand for these medications has led to significant shortages, affecting diabetes care.
Pharmaceutical companies are racing to develop new, more effective anti-obesity drugs.
Current GLP-1 drugs can be costly and cause side effects such as nausea and headaches.
Experts predict the GLP-1 market could reach $150 billion by 2029, with 28 million users.